Waverley Pharma Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was CAD 0.148593 million compared to CAD 0.421755 million a year ago. Net loss was CAD 0.240957 million compared to CAD 0.024042 million a year ago.
For the six months, sales was CAD 0.267279 million compared to CAD 0.725662 million a year ago. Net loss was CAD 0.580515 million compared to CAD 0.335032 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.